Gardasil 9 Suspension for Injection (IM)

Pays: Philippines

Langue: anglais

Source: FDA (Food And Drug Administration)

Ingrédients actifs:

Human Papillomavirus 9-Valent Vaccine (Recombinant, Adsorbed)

Disponible depuis:

N/A; Importer: Merck Sharp & Dohme (1.A.) LLC; Distributor: N/A

DCI (Dénomination commune internationale):

Human Papillomavirus 9-Valent Vaccine (Recombinant, Adsorbed)

Dosage:

Formulation: Each dose (0.5 mL) contains: Human Papillomavirus Type 6 1.1-30 mcg protein Human Papillomavirus Type 11 1.1 protein-40 mcg Human Papillomavirus Type 16 1.1 protein-60 mcg Human Papillomavirus Type 18 1.1 protein-40 mcg Human Papillomavirus Type 31 1.1 protein-20 mcg Human Papillomavirus Type 33 1.1 protein -20 mcg Human Papillomavirus Type 45 1.1 protein -20 mcg Human Papillomavirus Type 52 1.1 protein-20 mcg Human Papillomavirus Type 58 1.1 protein-20 mcg Adsorbed on amorphous aluminum hydroxyphosphate sulphate adjuvant (500 mcg Al)

forme pharmaceutique:

Suspension for Injection (IM)

Unités en paquet:

Single dose. 0.5 mL in 3 mL Ph. Eur./USP Type I glass vial with Fluro TecTM-laminated stopper and aluminum seal with brown plastic flip-off cap [Box of 10's), Single dose. 0.5 mL in 3 mL Ph. Eur./USP Type I glass vial with Fluro TecTM-laminated stopper and aluminum seal with brown plast

Fabriqué par:

Merck Sharp & Dohme Corporation, United States of America

Descriptif du produit:

Formulation: Each dose (0.5 mL) contains: Human Papillomavirus Type 6 1.1-30 mcg protein Human Papillomavirus Type 11 1.1 protein-40 mcg Human Papillomavirus Type 16 1.1 protein-60 mcg Human Papillomavirus Type 18 1.1 protein-40 mcg Human Papillomavirus Type 31 1.1 protein-20 mcg Human Papillomavirus Type 33 1.1 protein -20 mcg Human Papillomavirus Type 45 1.1 protein -20 mcg Human Papillomavirus Type 52 1.1 protein-20 mcg Human Papillomavirus Type 58 1.1 protein-20 mcg Adsorbed on amorphous aluminum hydroxyphosphate sulphate adjuvant (500 mcg Al)

Date de l'autorisation:

2022-08-05